comparemela.com

Latest Breaking News On - Robert margolin - Page 1 : comparemela.com

Natural Killer Cells: Progress and Promise, Upcoming Webinar Hosted by Xtalks

De-risking the Manufacturing of Cell Therapies through Virus-Inactivated Products, Upcoming Webinar Hosted by Xtalks

De-risking the Manufacturing of Cell Therapies through Virus-Inactivated Products, Upcoming Webinar Hosted by Xtalks Share Article In this free webinar, the featured speakers will discuss the challenges posed by human blood-derived ancillary materials and the strategies employed by suppliers to mitigate these risks. Attendees will also learn about a layered approach to providing safe and effective therapeutic biologics. As advanced therapies progress through the clinical pipeline, the integrity of the materials used during manufacture becomes increasingly critical. TORONTO (PRWEB) February 24, 2021 As advanced therapy developers approach approval and commercialization, they adopt increasingly robust risk-based approaches to ancillary material qualification. Ancillary material qualification is defined by USP 1043 as “the process of acquiring and evaluating data to establish the source, identity, purity, biologi

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.